单剂量脂质体布比卡因与留置镇痛导管在肋骨骨折手术稳定患者中的随机临床试验
这项非劣效性、单中心随机临床试验(2017-2020年)纳入34例接受肋骨骨折手术稳定的患者,随机分为留置镇痛导管组(IC,n=16)和单剂量脂质体布比卡因组(LB,n=18)。主要终点为术后5天每日测量的呼吸功能序贯临床评估评分,两组间无显著差异。术后第2至4天,LB组阿片类药物需求量不到IC组的一半,但差异未达统计学显著。IC组有3例失败,LB组有1例失败(p=0.23)。作者结论认为LB至少提供与IC相当且可能更优的区域镇痛。
要点
- 在肋骨骨折手术稳定患者中,单剂量脂质体布比卡因组与留置镇痛导管组呼吸功能序贯临床评估评分无显著差异。
- 术后第2至4天,脂质体布比卡因组阿片类药物需求量不到留置导管组的一半,但差异未达统计学显著。
- 主要区域镇痛失败:留置导管组3例 vs 脂质体布比卡因组1例(p=0.23)。
- 平均批发价:留置镇痛导管605美元 vs 脂质体布比卡因434美元。
- 证据等级:治疗性,II级。
适用人群与场景
- 接受肋骨骨折手术稳定(SSRF)的患者,2017-2020年单中心随机纳入。
处置流程与药物剂量
- 留置镇痛导管(IC):隧道置入手术野(肩胛下间隙),持续输注布比卡因,导管留置时间4.5天。
- 脂质体布比卡因(LB):胸腔镜下第3至第8肋间神经阻滞,单剂量给药。
研究设计与关键结果
- 非劣效性、单中心、随机临床试验(2017-2020年),共纳入34例:IC组16例,LB组18例。
- 两组年龄、损伤严重度评分、RibScore、钝性肺挫伤评分及非阿片类镇痛药使用相似。
- 主要终点呼吸功能序贯临床评估评分在IC组与LB组间无显著差异。
- 主要区域镇痛失败(需第二种区域镇痛方式):IC组3例 vs LB组1例(p=0.23)。
- 术后第2至4天,LB组阿片类药物需求量不到IC组的一半,但差异未达统计学显著。
- 平均批发价:IC组605美元 vs LB组434美元。
- 作者结论:LB至少提供与IC相当且可能更优的区域镇痛。
证据类型、等级与局限
- 证据类型:非劣效性、单中心、随机临床试验。
- 证据等级:治疗性,II级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在肋骨骨折手术稳定患者中,单剂量脂质体布比卡因至少提供与留置镇痛导管相当的局部区域镇痛,且可能更优。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Locoregional analgesia (LRA) remains underused in patients with chest wall injuries. Surgical stabilization of rib fractures (SSRF) offers an opportunity to deliver surgeon-directed LRA under direct visualization at the site of surgical intervention. We hypothesized that a single-dose liposomal bupivacaine (LB) intercostal nerve block provides comparable analgesia to an indwelling, peripheral nerve plane analgesic catheter with continuous bupivacaine infusion (IC), each placed during SSRF.
METHODS: Noninferiority, single-center, randomized clinical trial (2017-2020) was performed. Patients were randomized to receive either IC or LB during SSRF. The IC was tunneled into the surgical field (subscapular space), and LB involved thoracoscopic intercostal blocks of ribs 3 to 8. The primary outcome was the Sequential Clinical Assessment of Respiratory Function score, measured daily for 5 days postoperatively. Secondary outcomes included daily narcotic equivalents and failure of primary LRA, defined as requiring a second LRA modality.
RESULTS: Thirty-four patients were enrolled: 16 IC and 18 LB. Age, Injury Severity Score, RibScore, Blunt Pulmonary Contusion Score, and use of nonnarcotic analgesics was similar between groups. Duration of IC was 4.5 days. There were three failures in the IC group versus one in the LB group (p = 0.23). There was no significant difference in Sequential Clinical Assessment of Respiratory Function score between the IC and LB groups. On postoperative days 2 to 4, narcotic requirements were less than half in the LB, as compared with the IC group; however, this difference was not statistically significant. Average wholesale price was US $605 for IC and US $434 for LB.
CONCLUSION: In this noninferiority trial, LB provided at least comparable and potentially superior LRA as compared with IC among patients undergoing SSRF.
LEVEL OF EVIDENCE: Therapeutic, level II.
参考来源
- Leasia KN, Ciarallo C, Prins JTH, et al. A randomized clinical trial of single dose liposomal bupivacaine versus indwelling analgesic catheter in patients undergoing surgical stabilization of rib fractures. J Trauma Acute Care Surg. 2021. PMID: 33951024. doi:10.1097/TA.0000000000003264
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。